Nonacog Beta Pegol: Uses, Benefits, and Mechanism of Action

Overview

Nonacog beta pegol is a new type of drug that assists patients who have hemophilia B. Nonacog beta pegol improves the lives of patients who suffer from hemophilia B. Nonacog beta pegol includes a manufactured substitute for a protein that clots the blood and persists in the system longer than the usual treatment. Physicians administer it intravenously to prevent or treat bleeding. In large trials, it worked effectively for most patients, but some individuals could be allergic to it. As a whole, it helps people with hemophilia live easier lives. The FDA (Food and Drug Administration) approved this medication in 2017, and it has assisted many individuals suffering from hemophilia to live easy lives.

What Is the Drug Group?

It belongs to the recombinant coagulation factor IX drug group. It is prescribed for individuals with hemophilia B, a condition in which the blood fails to clot properly, leading to excessive bleeding. This drug provides them with a unique protein (factor IX) to prevent bleeding and future bleeding complications.

What Are the Uses of Nonacog Beta Pegol?

It is used in hemophilia B, a bleeding disorder.

Nonacog beta pegol is used in the following ways :

• To stop bleeding in hemophilic B patients (12 years and above).

• To prevent bleeding in hemophilic B patients (12 years and above).

A key thing to remember:

• It is not taken every day to prevent bleeding.

• It is not used to treat immune system issues with hemophilia B.

A physician will determine when it should be administered.

Nonacog beta pegol simplifies life for individuals with hemophilia by minimizing infusions, lowering the treatment stress, and offering improved coverage against unanticipated bleeds.

Dosage Forms and Available Strengths

Nonacog beta pegol is available as a white to off-white lyophilized (freeze-dried) powder in single-use vials.

1. Available Strengths:

• 500 IU per vial.

• 1000 IU per vial.

• 2000 IU per vial.

After mixing with 4 mL of histidine diluent, the final solution contains:

• 125 IU/mL for the 500 IU vial.

• 250 IU/mL for the 1000 IU vial.

• 500 IU/mL for the 2000 IU vial.

What Precautions and Warnings Should I Consider?

• There is a rare risk of allergic reactions to Nonacog beta pegol. When this happens, patients can elicit a variety of signs and symptoms, ranging from a skin rash to breathlessness. Hence, patients on Nonacog beta pegol should be monitored regularly.

• After using Nonacog beta pegol, patients with a central venous access device (CVAD) or who are on catheters are at risk for blood clots and infections.

• Individuals with serious medical issues or those who recently had surgery (such as heart disease, liver disease, cancer, etc.) tend to develop blood clots following the administration of Nonacog beta pegol.

• Those patients who possess risk factors like high blood pressure, abuse of tobacco, and obesity are also at risk of developing blood clots when they are given Nonacog beta pegol.

For Patients

How Does the Nonacog Beta Pegol Work?

Clotting is a collaboration effort that requires several proteins to work together. When an injury occurs, factor IX intervenes to trigger factor X, which facilitates clot formation to stop the bleeding. Nonacog beta pegol replicates the natural process by basically acting in place of missing factor IX.

Comparison to Natural Factor IX: What Is the Difference?

The greatest contrast between natural factor IX and Nonacog beta pegol is that the latter is designed to remain longer in the body. The intention is to lower the frequency of infusions and keep bleeding at bay. Imagine a long battery as opposed to one that's usual—you get to use it for longer before requiring a recharge.

What Is the Dosage of the Nonacog Beta Pegol?

The dosage of Nonacog beta pegol varies depending on its use in various medical situations. It is administered intravenously with the following doses.

• For Ceasing Bleeding: Typically, a dose of 40 international units or 40 IU per kg of body weight is prescribed to the patients, but the dose can be increased to 80 IU per kg of body weight, depending on the patient's requirements.

• For Prophylaxis Treatment to Prevent Bleeding: 40 international units or 40 IU per kg of body weight, administered weekly. However, the dosage can change depending on the patient's needs.

How Is Nonacog Beta Pegol Administered?

It is given through a vein (IV infusion) after being mixed with a liquid. The dose depends on the severity of the bleeding and the patient’s condition.

• Minor Bleeding (Like Small Muscle or Joint Bleeds): One dose is usually enough.

• Major Bleeding (Like Serious Internal Bleeding): A higher dose may be needed.

• Before Surgery: A dose is given to prevent bleeding, and extra doses may be needed after surgery.

1. Preparation: How Is It Done?

• Wash your hands and make sure everything is clean.

• Mix the medicine powder with the special liquid (diluent).

• Mix till all the powder dissolves.

• Draw the solution into a syringe.

• Inject it slowly into a vein over one to four minutes.

2. What Is GlycoPEGylation?

GlycoPEGylation incorporates polyethylene glycol (PEG) onto factor IX, making it stay in the blood for longer. It minimizes frequent infusions by giving a more stable and safe treatment with Nonacog beta pegol.

What Are the Side Effects of Nonacog Beta Pegol?

The side effects of Nonacog beta pegol include:

• Pruritis.

• Skin reaction at the site of administration.

• Nausea.

• Vomiting.

• Fatigue.

• Heart palpitations.

• Hot flashes.

Occasionally, the side effects can be severe. The following side effects are uncommon; however, the doctor must be informed immediately if these side effects occur.

• Difficulty in swallowing.

• Difficulty in breathing.

• Wheezing.

• Shortness of breath.

• Swelling of the lips, tongue, face, and hands.

• Skin rash, hives.

• Itchy skin.

• Cold and pale skin.

• Chest discomfort or chest tightness.

• Decreased blood pressure.

• Fast, irregular heartbeats.

• Loss of consciousness.

What Are the Things to Inform the Doctor Before Taking Nonacog Beta Pegol?

Patients should ensure the following before starting the doses of Nonacog beta pegol:

• They should inform the doctor of any previous history of allergies associated with the Nonacog beta pegol, its excipients, or any other medication.

• Patients should share their medical histories and inform their physicians of all the prescription and non-prescription medications they might be taking.

• Patients should inform the physician about a history of serious medical conditions such as heart diseases (heart attack, angina, hypertension, heart failure), liver diseases, cancer, etc.

• Patients should also be informed about the history of recent surgeries since this drug can make an individual susceptible to thromboembolic events.

• Pregnant patients or those planning on becoming pregnant in the immediate future should disclose this information to their doctors before starting the therapy with Nonacog beta pegol.

What Special Dietary Instructions Must Be Followed?

Unless advised by doctors, no dietary changes are required.

Missed Dose: Patients should contact their doctors about missing a scheduled dose so that the consequent dose can be administered.

How to Store Nonacog Beta Pegol?

• Keep it in the original box to protect it from light.

• Store it in the fridge (36°F to 46°F or 2°C to 8°C) for up to 24 months (2 years) or until the expiration date on the bottle.

• If needed, you can keep it at room temperature (not above 86°F or 30°C) for up to 6 months. On the box, write the date you took the medicine out of the fridge.

• Do not put it back in the fridge once it has been at room temperature.

• Do not freeze it.

• Discard the unused solution.

For Doctors

What Are the Pharmacological Actions of Nonacog Beta Pegol?

1. Pharmacodynamics: Nonacog beta pegol helps raise factor IX levels in the blood, which can temporarily improve clotting in people with hemophilia B. This makes their blood clot more normally, as shown by a shorter aPTT test time.

2. Mechanism of Action: Factor IXa and tissue complex factor VII cooperate to activate Nonacog beta pegol, splitting the peptide and the 40 kDa PEG moiety. This activation yields the same biological activity as endogenous coagulation factor IXa and recombinant factor IX. Activation of factor VIIIa and factor IX initiates a mechanism leading to the triggering of the coagulation cascade, using factor X, and the conversion of prothrombin to thrombin. Thrombin generation results in the transformation of fibrinogen to fibrin, which facilitates clot formation.

3. Pharmacokinetics: At steady state, it is approximately 70 hours in children, while in adults, it is 89 hours.

What Are the Contraindications of Nonacog Beta Pegol?

The following groups should avoid the use of this medication-

• Individuals with known allergies to hamster proteins.

• Avoid using Nonacog beta pegol in people who are allergic to it or any of its ingredients, including hamster proteins.

Alternatives to Nonacog Beta Pegol: What Are They?

If Nonacog beta pegol isn’t the right fit, there are other options available. Standard recombinant factor IX has been the go-to treatment for years—it's effective but requires more frequent infusions. Another exciting possibility is gene therapy, which is still being researched but could one day offer a one-time treatment that fixes the factor IX deficiency for good. This could mean no more regular infusions, making life much easier for people with hemophilia B.

What Are the Drug Interactions of Nonacog Beta Pegol?

There are no drug interactions with Nonacog beta pegol.

How Is Nonacog Beta Pegol Used in Specific Populations?

• Kidney Disease: In rare cases, the drug has caused kidney problems (nephrotic syndrome). Doctors should check kidney function regularly for safety.

• Pregnancy: If a person is pregnant or expecting pregnancy in the near future, they should be advised by the doctor beforehand while commencing the treatment using Nonacog beta pegol.

In the general U.S. population, about 2-4 % of pregnancies result in major birth defects and 15 to 20 percent end in miscarriage.

• Lactation: The lactating mother should consult a physician before starting therapy with Nonacog beta pegol to ensure its safety for both the mother and the baby.

• Allergies: Some people may experience allergic reactions to Nonacog beta pegol. To be safe, the first dose should be given in a clinic or hospital where you can be monitored for at least a day. Seek immediate medical help if you develop symptoms like swelling of the lips, mouth, or tongue, difficulty breathing, chest tightness, or hives.

• Children and Adolescents: It is only recommended for adolescents aged 12 and older, as well as adults.

Conclusion

For hemophilia B, Nonacog beta pegol is groundbreaking as it is injected less often and offers longer protection. Its benefits in minimizing bleeding events and overall quality of life are significant despite problems like cost and PEG accumulation. Even newer treatments like gene therapy may offer even better solutions as studies go on. Meanwhile, patients now have more control over their disease because of this new treatment. The future of treatment for hemophilia B is more promising than ever because of the fast pace of technological advancement.

Key Takeaway From iCliniq

Nonacog beta pegol is a cutting-edge recombinant factor IX for hemophilia B. iCliniq physicians offer their guidance for the same. Its longer half-life improves patient convenience by lowering the frequency of infusions. Better bleeding control is provided, although there are still issues with expense and PEG buildup. Experts at iCliniq think that with additional study, cutting-edge therapies like gene therapy might transform the way hemophilia is tackled.